Antithrombin III: Phase III

Antithrombin III failed to decrease 28-day all cause mortality versus placebo in an international,

Read the full 148 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE